Now showing items 1-10 of 349
Debacle: Trump’s Response to the COVID-19 Emergency
(2020-08-26)
Why did the United States, ranked as the world's best prepared country, fail so dramatically in its response to the COVID-19 pandemic? Part of the reason is the backdrop of a fragmented and largely market-driven health ...
Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan
(Oxford University Press, 2020-04)
Firearm violence among LGBTQ+ communities: Scoping Review Protocol
(2021-04-07)
Description of public health problem: In the general population, firearms are one of the most common means of suicide. The lethality of firearms creates a higher risk of mortality in a suicide attempt with a firearm compared ...
Coronavirus disease 2019 (COVID-19): A literature review
(2020-04-08)
In early December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan City, Hubei Province, China. On January 30, 2020 ...
Differential propagation of ripples along the proximodistal and septotemporal axes of dorsal CA1 of rats
(John Wiley & Sons, Inc., 2020-09)
The functional connectivity of the hippocampus with its primary cortical input, the entorhinal cortex, is organized topographically. In area CA1 of the hippocampus, this leads to different functional gradients along the ...
How well do doctors know their patients? Evidence from a mandatory access prescription drug monitoring program
(Stata PressWiley Periodicals, Inc., 2020-09)
Many opioid control policies target the prescribing behavior of health care providers. In this paper, we study the first comprehensive state‐level policy requiring providers to access patients’ opioid history before making ...
Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children’s Oncology Group
(Lippincott Williams and WilkinsWiley Periodicals, Inc., 2020-08-01)
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial
(Bristol‐Myers Squibb CompanyWiley Periodicals, Inc., 2020-09-15)